ppm 18 has been researched along with bufexamac in 1 studies
*Bufexamac: A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally. [MeSH]
*Bufexamac: A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergman, JA; Kalin, JH | 1 |
1 review(s) available for ppm 18 and bufexamac
| Article | Year |
|---|---|
Development and therapeutic implications of selective histone deacetylase 6 inhibitors.
Topics: Disease; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans | 2013 |